Novo vs. KBP: How a $1.3B deal turned into an international legal fight
Closeup of blue eye on black background
Biotech

Lilly buys cash-strapped Adverum for eye disease gene therapy

Just as Adverum’s cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy.
James Waldron Oct 24, 2025 9:25am
Bringing clinical trials to the community a new model for precision enrollment

Bringing clinical trials to the community: a new model for precision enrollment

Oct 20, 2025 8:00am
Glowing puzzle piece fitting into puzzle

Biogen pens $1B deal for Vanqua's preclinical C5aR1 antagonist

Oct 24, 2025 9:15am
Redefining Biotech How AI and Real-World Data Power Patient-Centered Progress

Redefining Biotech: AI, RWD, and Patient-Centered Progress

Oct 20, 2025 8:00am
Rendered image of a respiratory syncytial virus

Sanofi drops toddler RSV vaccine after ph. 3 heads for failure

Oct 24, 2025 7:00am
Model skeleton in anatomy class

Inhibrx intends FDA submission after phase 2 bone cancer win

Oct 24, 2025 6:40am
More News

Fierce 15: Where are they now?

Oct 24, 2025 9:00am

Former Aurion chief vaults to Valitor—Chutes & Ladders

Oct 24, 2025 8:30am
Fierce Healthcare

Government shutdown updates: CMS recalls furloughed workers

Oct 23, 2025 1:00pm

Regeneron does 180 on 2seventy lymphoma CAR-T

Oct 23, 2025 10:57am